Repligen | RGEN - Equity Capital And Reserves

Stock Price
139.28
Daily Change
-6.83 -4.67%
Monthly
-19.15%
Yearly
-13.95%
Q1 Forecast
144.77

Repligen reported $442.96M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Agilent USD 6.74B 371M Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
Bio Techne USD 2.01B 45.18M Dec/2025
BioMarin Pharmaceutical USD 6.06B 29.6M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Bruker USD 2.49B 625.6M Sep/2025
Charles River Laboratories USD 3.41B 52.13M Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Exact Sciences USD 2.5B 32M Sep/2025
General Electric Aerospace USD 18.9B 86M Dec/2025
Henry Schein USD 3.36B 84M Sep/2025
Illumina USD 2.38B 123M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Mettler Toledo International USD -249.2M 9.59M Sep/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Repligen USD 442.96M 1.62B Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Standard Biotools USD 399.66M 24.88M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.33B 170.88M Sep/2025
West Pharmaceutical Services USD 3.05B 122.4M Sep/2025